share_log

復星醫藥：截至2024年3月31日之股份發行人的證券變動月報表

FOSUN PHARMA: MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2024

香港交易所 ·  Apr 2 04:41
Summary by Moomoo AI
上海復星醫藥股份有限公司於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的H股（股份代號02196）和A股（股份代號600196）在過去一個月內均無股份數目的增減，H股和A股的結存股份數目分別為551,940,500股和2,120,458,211股，每股面值均為1人民幣。報告中亦確認，公司在本月內發行的所有證券均已獲得董事會的正式授權，並已履行所有上市前的法定要求。卓佳證券登記有限公司作為H股股份過戶登記處，負責呈交本次報告。
上海復星醫藥股份有限公司於2024年4月2日向香港交易及結算所有限公司提交了最新的證券變動月報表，報告截至2024年3月31日的股份變動情況。報告顯示，公司的H股（股份代號02196）和A股（股份代號600196）在過去一個月內均無股份數目的增減，H股和A股的結存股份數目分別為551,940,500股和2,120,458,211股，每股面值均為1人民幣。報告中亦確認，公司在本月內發行的所有證券均已獲得董事會的正式授權，並已履行所有上市前的法定要求。卓佳證券登記有限公司作為H股股份過戶登記處，負責呈交本次報告。
SHANGHAI FUSTAR PHARMACEUTICAL CO., LTD. SUBMITTED ITS LATEST SECURITIES MONTH CHANGE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 2, 2024, REPORTING THE STOCK CHANGES AS OF MARCH 31, 2024. The report shows that the company's H shares (stock code 02196) and A shares (share code 600196) have not decreased in the number of shares in the past month. The number of shares outstanding for H shares and A shares was 551,940,500 shares and 2,120,458,211 shares, respectively, with an average value of RMB 1. The report also confirms that all securities issued by the Company during this month have been formally authorized by the Board of Directors and have complied with all pre-listing regulatory requirements. JUJIA SECURITIES REGISTRATION COMPANY LIMITED IS RESPONSIBLE FOR SUBMITTING THIS REPORT AS THE REGISTRAR OF H SHARES.
SHANGHAI FUSTAR PHARMACEUTICAL CO., LTD. SUBMITTED ITS LATEST SECURITIES MONTH CHANGE REPORT TO HONG KONG TRADING AND SETTLEMENT LIMITED ON APRIL 2, 2024, REPORTING THE STOCK CHANGES AS OF MARCH 31, 2024. The report shows that the company's H shares (stock code 02196) and A shares (share code 600196) have not decreased in the number of shares in the past month. The number of shares outstanding for H shares and A shares was 551,940,500 shares and 2,120,458,211 shares, respectively, with an average value of RMB 1. The report also confirms that all securities issued by the Company during this month have been formally authorized by the Board of Directors and have complied with all pre-listing regulatory requirements. JUJIA SECURITIES REGISTRATION COMPANY LIMITED IS RESPONSIBLE FOR SUBMITTING THIS REPORT AS THE REGISTRAR OF H SHARES.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more